Composite lymphoma of concurrent T zone lymphoma and large cell B cell lymphoma in a dog
Abstract Background Evolution of indolent to aggressive lymphoma has been described in dogs but is difficult to distinguish from the de novo development of a second, clonally distinct lymphoma. Differentiation of these scenarios can be aided by next generation sequencing (NGS)-based assessment of cl...
Main Authors: | Arata Matsuyama, Dorothee Bienzle, Danielle Richardson, Nariman Deravi, Mei-Hua Hwang, Nikos Darzentas, Stefan M. Keller |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | BMC Veterinary Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12917-019-2154-8 |
Similar Items
-
Secondary lymphoma development after chemotherapy in three dogs
by: Jeong Mi Kim, et al.
Published: (2021-07-01) -
Genetic and environmental risk for lymphoma in boxer dogs
by: Kaitlyn Craun, et al.
Published: (2020-09-01) -
Concurrent use of rabacfosadine and L‐asparaginase for relapsed or refractory multicentric lymphoma in dogs
by: Jacob R. Cawley, et al.
Published: (2020-03-01) -
L-Asparaginase, Doxorubicin, Vincristine, and Prednisolone (LHOP) Chemotherapy as a First-Line Treatment for Dogs with Multicentric Lymphoma
by: Jih-Jong Lee, et al.
Published: (2021-07-01) -
Use of immune repertoire sequencing to resolve discordant microscopic and immunochemical findings in a case of T cell-rich large B cell lymphoma in a young dog
by: Gary Kwok Cheong Lee, et al.
Published: (2021-02-01)